EVIDENCE WATCH
A review and assessment of recent clinical trial data

Prostate cancer
DOCETAXEL PLUS PREDNISONE OR MITOXANTRONE PLUS PREDNISONE FOR ADVANCED PROSTATE CANCER

DOCETAXEL AND ESTRAMUSTINE COMPARED WITH MITOXANTRONE AND PREDNISONE FOR ADVANCED REFRACTORY PROSTATE CANCER

 

To view the clinical trial data of the above topics click here (pdf format)
Back to Top of Page 

 

 
 
 
This issue of Oncology Exchange provides overviews of important clinical trial data originally presented at the 40th Annual Meeting of the American Society of Clinical Oncology (ASCO), held in New Orleans, LA, June 5-9, 2004. Leading Canadian experts offer commentary and clinical interpretations.
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
 Site created by Spin Design (514) 995-4398